3P01AG017586-20S1 |
2021 |
$711440 |
None |
Frontotemporal Dementias: Genotypes and Phenotypes |
LEE, VIRGINIA M |
5P01AG017586-20 |
2020 |
$95380 |
8496 |
Administrative Core |
LEE, VIRGINIA M |
5P01AG017586-20 |
2020 |
$283343 |
8497 |
Clinical Core |
GROSSMAN, MURRAY |
5P01AG017586-20 |
2020 |
$211399 |
8498 |
Genetics Core |
VAN DEERLIN, VIVIANNA M |
5P01AG017586-20 |
2020 |
$129645 |
8499 |
Neuropathology and Biomarkers Core |
TROJANOWSKI, JOHN Q |
5P01AG017586-20 |
2020 |
$133942 |
8500 |
Biostatistics and Data Management Core |
XIE, SHARON XIANGWEN |
5P01AG017586-20 |
2020 |
$335468 |
8501 |
Project 1: Mutimodal Endophenotyping of Spreading Human Tauopathy |
GROSSMAN, MURRAY |
5P01AG017586-20 |
2020 |
$312187 |
8502 |
Project 2: Genetic Modifiers of Tauopathies |
SCHELLENBERG, GERARD DAVID |
5P01AG017586-20 |
2020 |
$341742 |
8503 |
Project 3: Mechanisms of Tauopathies |
LEE, VIRGINIA M |
5P01AG017586-20 |
2020 |
$351101 |
8504 |
Project 4: Pathologic Tau Strains Underlying FTLD-Tau Variants |
TROJANOWSKI, JOHN Q |
5P01AG017586-19 |
2019 |
$344677 |
8501 |
Project 1: Mutimodal Endophenotyping of Spreading Human Tauopathy |
GROSSMAN, MURRAY |
5P01AG017586-19 |
2019 |
$313268 |
8502 |
Project 2: Genetic Modifiers of Tauopathies |
SCHELLENBERG, GERARD DAVID |
5P01AG017586-19 |
2019 |
$349201 |
8503 |
Project 3: Mechanisms of Tauopathies |
LEE, VIRGINIA M |
5P01AG017586-19 |
2019 |
$356116 |
8504 |
Project 4: Pathologic Tau Strains Underlying FTLD-Tau Variants |
TROJANOWSKI, JOHN Q |
5P01AG017586-19 |
2019 |
$97798 |
8496 |
Administrative Core |
LEE, VIRGINIA M |
5P01AG017586-19 |
2019 |
$291381 |
8497 |
Clinical Core |
GROSSMAN, MURRAY |
5P01AG017586-19 |
2019 |
$215056 |
8498 |
Genetics Core |
VAN DEERLIN, VIVIANNA M |
5P01AG017586-19 |
2019 |
$131527 |
8499 |
Neuropathology and Biomarkers Core |
TROJANOWSKI, JOHN Q |
5P01AG017586-19 |
2019 |
$135630 |
8500 |
Biostatistics and Data Management Core |
XIE, SHARON XIANGWEN |
5P01AG017586-18 |
2018 |
$100152 |
8496 |
Administrative Core |
LEE, VIRGINIA M |
5P01AG017586-18 |
2018 |
$299152 |
8497 |
Clinical Core |
GROSSMAN, MURRAY |
5P01AG017586-18 |
2018 |
$218607 |
8498 |
Genetics Core |
VAN DEERLIN, VIVIANNA M |
5P01AG017586-18 |
2018 |
$133597 |
8499 |
Neuropathology and Biomarkers Core |
TROJANOWSKI, JOHN Q |
5P01AG017586-18 |
2018 |
$137270 |
8500 |
Biostatistics and Data Management Core |
XIE, SHARON XIANGWEN |
5P01AG017586-18 |
2018 |
$353541 |
8501 |
Project 1: Mutimodal Endophenotyping of Spreading Human Tauopathy |
GROSSMAN, MURRAY |
5P01AG017586-18 |
2018 |
$328886 |
8502 |
Project 2: Genetic Modifiers of Tauopathies |
SCHELLENBERG, GERARD DAVID |
5P01AG017586-18 |
2018 |
$356443 |
8503 |
Project 3: Mechanisms of Tauopathies |
LEE, VIRGINIA M |
5P01AG017586-18 |
2018 |
$360984 |
8504 |
Project 4: Pathologic Tau Strains Underlying FTLD-Tau Variants |
TROJANOWSKI, JOHN Q |
5P01AG017586-17 |
2017 |
$363471 |
8503 |
PROJECT 3: MECHANISMS OF TAUOPATHIES |
LEE, VIRGINIA M |
5P01AG017586-17 |
2017 |
$365708 |
8504 |
PROJECT 4: PATHOLOGIC TAU STRAINS UNDERLYING FTLD-TAU VARIANTS |
TROJANOWSKI, JOHN Q |
5P01AG017586-17 |
2017 |
$101751 |
8496 |
Administrative Core |
LEE, VIRGINIA M |
5P01AG017586-17 |
2017 |
$147693 |
8500 |
Biostatistics and Data Management Core |
XIE, SHARON XIANGWEN |
5P01AG017586-17 |
2017 |
$306675 |
8497 |
Clinical Core |
GROSSMAN, MURRAY |
5P01AG017586-17 |
2017 |
$2337667 |
None |
FRONTOTEMPORAL DEMENTIAS: GENOTYPES AND PHENOTYPES |
LEE, VIRGINIA M |
5P01AG017586-17 |
2017 |
$222055 |
8498 |
Genetics Core |
VAN DEERLIN, VIVIANNA M |
5P01AG017586-17 |
2017 |
$135129 |
8499 |
Neuropathology and Biomarkers Core |
TROJANOWSKI, JOHN Q |
5P01AG017586-17 |
2017 |
$362077 |
8501 |
PROJECT 1: MUTIMODAL ENDOPHENOTYPING OF SPREADING HUMAN TAUOPATHY |
GROSSMAN, MURRAY |
5P01AG017586-17 |
2017 |
$333108 |
8502 |
Project 2: Genetic Modifiers of Tauopathies |
SCHELLENBERG, GERARD DAVID |
2P01AG017586-16 |
2016 |
$313788 |
8497 |
CLINICAL CORE |
GROSSMAN, MURRAY |
2P01AG017586-16 |
2016 |
$2394324 |
None |
FRONTOTEMPORAL DEMENTIAS: GENOTYPES AND PHENOTYPES |
LEE, VIRGINIA M |
2P01AG017586-16 |
2016 |
$225283 |
8498 |
GENETICS CORE |
VAN DEERLIN, VIVIANNA M |
2P01AG017586-16 |
2016 |
$136779 |
8499 |
NEUROPATHOLOGY AND BIOMARKERS CORE |
TROJANOWSKI, JOHN Q |
2P01AG017586-16 |
2016 |
$370108 |
8501 |
PROJECT 1: MUTIMODAL ENDOPHENOTYPING OF SPREADING HUMAN TAUOPATHY |
GROSSMAN, MURRAY |
2P01AG017586-16 |
2016 |
$352291 |
8502 |
PROJECT 2: GENETIC MODIFIERS OF TAUOPATHIES |
SCHELLENBERG, GERARD DAVID |
2P01AG017586-16 |
2016 |
$370108 |
8503 |
PROJECT 3: MECHANISMS OF TAUOPATHIES |
LEE, VIRGINIA M |
2P01AG017586-16 |
2016 |
$370108 |
8504 |
PROJECT 4: PATHOLOGIC TAU STRAINS UNDERLYING FTLD-TAU VARIANTS |
TROJANOWSKI, JOHN Q |
2P01AG017586-16 |
2016 |
$104597 |
8496 |
ADMINISTRATIVE CORE |
LEE, VIRGINIA M |
2P01AG017586-16 |
2016 |
$151262 |
8500 |
BIOSTATISTICS AND DATA MANAGEMENT CORE |
XIE, SHARON XIANGWEN |
5P01AG017586-15 |
2015 |
$77108 |
8571 |
ADMINISTRATIVE CORE |
LEE, VIRGINIA M |
5P01AG017586-15 |
2015 |
$113336 |
8575 |
BIOSTATISTICS AND DATA MANAGEMENT CORE |
XIE, SHARON XIANGWEN |
5P01AG017586-15 |
2015 |
$233061 |
8572 |
CLINICAL CORE |
GROSSMAN, MURRAY |
5P01AG017586-15 |
2015 |
$274665 |
8578 |
COGNITIVE AND NEURAL IMPAIRMENT IN FTLD |
GROSSMAN, MURRAY |
5P01AG017586-15 |
2015 |
$263833 |
8576 |
GENETIC MODIFIERS OF TAUOPATHIES |
SCHELLENBERG, GERARD DAVID |
5P01AG017586-15 |
2015 |
$168778 |
8573 |
GENETICS CORE |
VAN DEERLIN, VIVIANNA M |
5P01AG017586-15 |
2015 |
$255943 |
8577 |
MECHANISMS OF PATHOGENESIS |
LEE, VIRGINIA M |
5P01AG017586-15 |
2015 |
$104130 |
8574 |
NEUROPATHOLOGY CORE |
TROJANOWSKI, JOHN Q |
5P01AG017586-15 |
2015 |
$281339 |
8579 |
PATHOLOGIC MODIFIERS OF TDP-43 PROTEINOPATHIES |
TROJANOWSKI, JOHN Q |
5P01AG017586-14 |
2014 |
$278219 |
8576 |
GENETIC MODIFIERS OF TAUOPATHIES |
SCHELLENBERG, GERARD DAVID |
5P01AG017586-14 |
2014 |
$177365 |
8573 |
GENETICS CORE |
VAN DEERLIN, VIVIANNA M |
5P01AG017586-14 |
2014 |
$267683 |
8577 |
MECHANISMS OF PATHOGENESIS |
LEE, VIRGINIA M |
5P01AG017586-14 |
2014 |
$108605 |
8574 |
NEUROPATHOLOGY CORE |
TROJANOWSKI, JOHN Q |
5P01AG017586-14 |
2014 |
$293532 |
8579 |
PATHOLOGIC MODIFIERS OF TDP-43 PROTEINOPATHIES |
TROJANOWSKI, JOHN Q |
5P01AG017586-14 |
2014 |
$81074 |
8571 |
ADMINISTRATIVE CORE |
LEE, VIRGINIA M |
5P01AG017586-14 |
2014 |
$119049 |
8575 |
BIOSTATISTICS AND DATA MANAGEMENT CORE |
XIE, SHARON XIANGWEN |
5P01AG017586-14 |
2014 |
$245042 |
8572 |
CLINICAL CORE |
GROSSMAN, MURRAY |
5P01AG017586-14 |
2014 |
$288722 |
8578 |
COGNITIVE AND NEURAL IMPAIRMENT IN FTLD |
GROSSMAN, MURRAY |
5P01AG017586-14 |
2014 |
$1859291 |
None |
FRONTOTEMPORAL DEMENTIAS: GENOTYPES AND PHENOTYPES |
LEE, VIRGINIA M |
5P01AG017586-13 |
2013 |
$78143 |
8571 |
ADMINISTRATIVE CORE |
LEE, VIRGINIA M |
5P01AG017586-13 |
2013 |
$115115 |
8575 |
BIOSTATISTIC AND DATA MANAGEMENT CORE |
XIE, SHARON XIANGWEN |
5P01AG017586-13 |
2013 |
$236166 |
8572 |
CLINICAL CORE |
GROSSMAN, MURRAY |
5P01AG017586-13 |
2013 |
$278198 |
8578 |
COGNITIVE AND NEURAL IMPAIRMENT IN FTLD |
GROSSMAN, MURRAY |
5P01AG017586-13 |
2013 |
$269028 |
8576 |
GENETIC MODIFIERS OF TAUOPATHIES |
SCHELLENBERG, GERARD DAVID |
5P01AG017586-13 |
2013 |
$171278 |
8573 |
GENETICS CORE |
VAN DEERLIN, VIVIANNA M |
5P01AG017586-13 |
2013 |
$256646 |
8577 |
MECHANISMS OF PATHOGENESIS |
LEE, VIRGINIA M |
5P01AG017586-13 |
2013 |
$103846 |
8574 |
NEUROPATHOLOGY CORE |
TROJANOWSKI, JOHN Q |
5P01AG017586-13 |
2013 |
$280748 |
8579 |
PATHOLOGIC MODIFIERS OF TDP-43 PROTEINOPATHIES |
TROJANOWSKI, JOHN Q |
5P01AG017586-12 |
2012 |
$111311 |
8574 |
NEUROPATHOLOGY CORE |
TROJANOWSKI, JOHN Q |
5P01AG017586-12 |
2012 |
$300920 |
8579 |
PATHOLOGIC MODIFIERS OF TDP-43 PROTEINOPATHIES |
TROJANOWSKI, JOHN Q |
5P01AG017586-12 |
2012 |
$83602 |
8571 |
ADMINISTRATIVE CORE |
LEE, VIRGINIA M |
5P01AG017586-12 |
2012 |
$122760 |
8575 |
BIOSTATISTIC AND DATA MANAGEMENT CORE |
XIE, SHARON XIANGWEN |
5P01AG017586-12 |
2012 |
$252787 |
8572 |
CLINICAL CORE |
GROSSMAN, MURRAY |
5P01AG017586-12 |
2012 |
$297426 |
8578 |
COGNITIVE AND NEURAL IMPAIRMENT IN FTLD |
GROSSMAN, MURRAY |
5P01AG017586-12 |
2012 |
$1932056 |
None |
Frontotemporal Dementias: Genotypes and Phenotypes |
LEE, VIRGINIA M |
5P01AG017586-12 |
2012 |
$289455 |
8576 |
GENETIC MODIFIERS OF TAUOPATHIES |
SCHELLENBERG, GERARD DAVID |
5P01AG017586-12 |
2012 |
$182837 |
8573 |
GENETICS CORE |
VAN DEERLIN, VIVIANNA M |
5P01AG017586-12 |
2012 |
$290958 |
8577 |
MECHANISMS OF PATHOGENESIS |
LEE, VIRGINIA M |
2P01AG017586-11 |
2011 |
$255842 |
8572 |
CLINICAL CORE |
GROSSMAN, MURRAY |
2P01AG017586-11 |
2011 |
$297525 |
8578 |
COGNITIVE AND NEURAL IMPAIRMENT IN FTLD |
GROSSMAN, MURRAY |
2P01AG017586-11 |
2011 |
$306795 |
8576 |
GENETIC MODIFIERS OF TAUOPATHIES |
SCHELLENBERG, GERARD DAVID |
2P01AG017586-11 |
2011 |
$296411 |
8577 |
MECHANISMS OF PATHOGENESIS |
LEE, VIRGINIA M |
2P01AG017586-11 |
2011 |
$301758 |
8579 |
PATHOLOGIC MODIFIERS OF TDP-43 PROTEINOPATHIES |
TROJANOWSKI, JOHN Q |
5P01AG017586-10 |
2009 |
$413306 |
1 |
COGNITIVE & NEURAL IMPAIRMENT IN FRONTOTEMPORAL DEMENTIA |
GROSSMAN, MURRAY |
5P01AG017586-10 |
2009 |
$290721 |
2 |
GENETIC ANALYSIS OF TAUPATHIES |
SCHELLENBERG, GERARD DAVID |
5P01AG017586-10 |
2009 |
$449670 |
4 |
TRANSGENIC MOUSE MODELS OF TAU PATHOLOGIES |
TROJANOWSKI, JOHN Q |
5P01AG017586-10 |
2009 |
$395288 |
3 |
BIOCHEMICAL AND IMMUNOHISTOCHEMICAL ANALYSIS OF FTDS |
LEE, VIRGINIA M |
5P01AG017586-09 |
2008 |
$386116 |
3 |
BIOCHEMICAL AND IMMUNOHISTOCHEMICAL ANALYSIS OF FTDS |
LEE, VIRGINIA M |
5P01AG017586-09 |
2008 |
$403129 |
1 |
COGNITIVE & NEURAL IMPAIRMENT IN FRONTOTEMPORAL DEMENTIA |
GROSSMAN, MURRAY |
5P01AG017586-09 |
2008 |
$285573 |
2 |
GENETIC ANALYSIS OF TAUPATHIES |
SCHELLENBERG, GERARD DAVID |
5P01AG017586-09 |
2008 |
$254579 |
9001 |
GENETICS CORE |
VAN DEERLIN, VIVIANNA M |
5P01AG017586-09 |
2008 |
$438506 |
4 |
TRANSGENIC MOUSE MODELS OF TAU PATHOLOGIES |
TROJANOWSKI, JOHN Q |